125 related articles for article (PubMed ID: 33574946)
1.
Maruyama K; Okada T; Ueha T; Isohashi K; Ikeda H; Kanai Y; Sasaki K; Gentsu T; Ueshima E; Sofue K; Nogami M; Yamaguchi M; Sugimoto K; Sakai Y; Hatazawa J; Murakami T
Oncol Lett; 2021 Mar; 21(3):207. PubMed ID: 33574946
[TBL] [Abstract][Full Text] [Related]
2. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
3. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
Okamoto S; Shiga T; Yasuda K; Watanabe S; Hirata K; Nishijima KI; Magota K; Kasai K; Onimaru R; Tuchiya K; Kuge Y; Shirato H; Tamaki N
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2147-2154. PubMed ID: 27251644
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor hypoxia in spontaneous canine tumors after treatment with OMX, a novel H-NOX oxygen carrier, with [
Choen S; Kent MS; Loucks FA; Winger JA; Zwingenberger AL
BMC Vet Res; 2024 May; 20(1):196. PubMed ID: 38741109
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with
Kawamura M; Yoshimura M; Shimizu Y; Sano K; Ishimori T; Nakamoto Y; Mizowaki T; Hiraoka M
Mol Imaging Biol; 2021 Aug; 23(4):597-603. PubMed ID: 33475945
[TBL] [Abstract][Full Text] [Related]
6.
Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic volume evaluated by
Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N
Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021
[TBL] [Abstract][Full Text] [Related]
8. Evaluating cardiac hypoxia in hibernating myocardium: Comparison of
Jagtap R; Asopa RV; Basu S
World J Nucl Med; 2019; 18(1):30-35. PubMed ID: 30774543
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
10.
Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):261-270. PubMed ID: 28734696
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia:
Watabe T; Kanai Y; Ikeda H; Horitsugi G; Matsunaga K; Kato H; Isohashi K; Abe K; Shimosegawa E; Hatazawa J
EJNMMI Res; 2017 Dec; 7(1):16. PubMed ID: 28210996
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.
Kikuchi M; Yamane T; Shinohara S; Fujiwara K; Hori SY; Tona Y; Yamazaki H; Naito Y; Senda M
Ann Nucl Med; 2011 Nov; 25(9):625-33. PubMed ID: 21720778
[TBL] [Abstract][Full Text] [Related]
13. Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors.
Yu W; Su X; Zhang D; Qiao F; Wang H; Jiang J; Xu H
Front Oncol; 2020; 10():1046. PubMed ID: 32766135
[No Abstract] [Full Text] [Related]
14.
Zhang MY; Zhang RJ; Jiang HJ; Jiang H; Xu HL; Pan WB; Wang YQ; Li X
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):164-172. PubMed ID: 30850340
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
16. Influence of the scan time point when assessing hypoxia in
Kobayashi K; Manabe O; Hirata K; Yamaguchi S; Kobayashi H; Terasaka S; Toyonaga T; Furuya S; Magota K; Kuge Y; Kudo K; Shiga T; Tamaki N
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1833-1842. PubMed ID: 31781832
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia predicts favorable response to carbon ion radiotherapy in non-small cell lung cancer (NSCLC) defined by
Liu M; Ma N; Ren C; Song S; Wu K; Sun Y; Mao J; Cheng J
Quant Imaging Med Surg; 2024 May; 14(5):3489-3500. PubMed ID: 38720866
[TBL] [Abstract][Full Text] [Related]
18. Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
Arvold ND; Heidari P; Kunawudhi A; Sequist LV; Mahmood U
Technol Cancer Res Treat; 2016 Apr; 15(2):234-42. PubMed ID: 25759424
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
20. (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
Toyonaga T; Hirata K; Yamaguchi S; Hatanaka KC; Yuzawa S; Manabe O; Kobayashi K; Watanabe S; Shiga T; Terasaka S; Kobayashi H; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1469-76. PubMed ID: 26841941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]